NEW YORK (GenomeWeb News) — CollabRx and CellNetix Pathology & Laboratories have signed a multi-year agreement that lets CellNetix make use of CollabRx's technology and content resources in providing sequencing-based testing for oncology.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.
Cancer clinical trial patients settle with Anil Potti and Duke University.
A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.
Two Johns Hopkins researchers discuss the need for evidence-based data analysis.
This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.